The Global Dialysis Device and Concentrates Market is poised for significant growth, with a projected value of US$ 34,824.85 million by 2033, according to market forecasts. This translates to a Compound Annual Growth Rate (CAGR) of 4.9% from a base of US$ 21,663.5 million in 2023.
To Get More Insights, Sample Report Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-2553
This growth is attributed to several key factors:
- Rising Prevalence of Kidney Disease: The increasing number of individuals diagnosed with kidney failure, often caused by conditions like hypertension and diabetes, fuels the demand for dialysis treatments.
- Limited Organ Availability: The lack of readily available organs for kidney transplants creates a growing population reliant on dialysis for survival.
- Technological Advancements: Research and development efforts are leading to the creation of high-tech dialysis devices, further propelling the use of hemodialysis and the need for dialysis concentrate.
- Growth of Dialysis Options: The expanding presence of dialysis clinics, along with the rise of home and nocturnal dialysis options, makes treatment more accessible, contributing to market growth, particularly in developing nations.
- Government Support: Government initiatives supporting patients with End-Stage Renal Disease (ESRD) further drive the expansion of dialysis treatments across the globe.
- Strategic Partnerships: Key players in the market are actively pursuing strategic agreements and partnerships with regional and domestic companies to increase their market reach and tap into new customer segments.
- Focus on Emerging Markets: Market participants are increasingly focusing on technological advancements that cater to the specific needs of developing countries, creating significant growth opportunities in these regions.
Global Dialysis Device and Concentrates Market Key Takeaways:
- By 2033, the dialysis device and concentrate market in the United Kingdom is likely to expand, with a CAGR of 4.3%.
- In 2022, the United States developed the dialysis device and focused business with a share of 33.8%.
- The dialysis device and concentrates market grew considerably to US$ 20,858 million in 2022.
- The dialysis device and concentrates market expanded with a CAGR of 3.1% between 2018 to 2022.
- By 2033, China’s dialysis device and concentrate market are projected to develop with a CAGR of 6.5%.
- By 2033, India’s dialysis device and concentrates industry is projected to expand with a CAGR of 3.1%.
- Japan’s dialysis device and concentrates industry grew significantly, with a 1.6% share in 2022.
- Australia’s dialysis device and concentrate market is likely to expand with a CAGR of 1.0% by 2033.
- Germany’s dialysis device and concentrates business grew, with a share of 7.5% in 2022
- In 2022, based on product, hemodialysis machines dominated the market, with a share of 34.2%.
- In 2022, the hospitals’ segment led the market, with a share of 37.6%, based on end users.
Immerse Yourself In The World Of Insightful Methodologies: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-2553
Key Players’ Strategies and Recent Developments:
- Medtronic introduced a dialysis device for newborn and pediatric care in the United States in December 2020. Additionally, in January 2021, the United States Food and Drug Administration granted 510(k) clearance to Quanta Dialysis Technologies Ltd, a British medical technology leader developing cutting-edge dialysis products and services, allowing it to market its compact, easy-to-use SC+ hemodialysis system.
- Rockwell Medical, Inc. stated in April 2022 that it had expanded its cooperation with DaVita Inc. and is revising some aspects of its supply contracts with clients to stabilize its concentrated business.
- The SURDIAL DX Hemodialysis System was introduced in the US in March 2022 by Nipro Medical Company, a producer and seller of renal, vascular, and medical-surgical devices.
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- DaVita Healthcare Partners, Inc.
- Nipro Corporation
- Asahi Kasei Medical Co. Ltd.
- Mar Cor Purification, Inc.
- Nikkiso Co Ltd.
- NxStage Medical, Inc.
- Rockwell Medical
- Farmasol
- Browndove Healthcare
Act Now to Explore In-Depth Market Analysis: Purchase Now to Access Expert Opinions: https://www.futuremarketinsights.com/checkout/2553
Global Dialysis Device and Concentrates Market Key segments:
By Product Type:
- Hemodialysis Machine
- A.V. Fistula Needle
- A.V. Access Graft
- Dialysis Catheter
- Dialysis Concentrates
- Dialyzer
- Dialyzer Reprocessing Machine
- Hemodialysis Bloodline and Tubing Set
- Declotting Device
- Water Treatment System
- introducer Sheath and Guidewire
By End-User:
- In-center Dialysis
- Hospitals
- Independent Dialysis Centres
- Home Dialysis
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
